查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018507

一次性内视镜市场：2026-2032年全球市场预测，依产品、类型、应用、最终用户及通路划分

Disposable Endoscopes Market by Product, Type, Application, End-User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，一次性内视镜市场价值将达到 19.8 亿美元，到 2026 年将成长至 22.5 亿美元，到 2032 年将达到 52.7 亿美元，复合年增长率为 14.95%。

主要市场统计数据
基准年 2025 19.8亿美元
预计年份：2026年 22.5亿美元
预测年份 2032 52.7亿美元
复合年增长率 (%) 14.95%

简要介绍一次性内视镜的快速普及，以及感染控制、工作流程效率和临床期望如何重新定义手术护理。

一次性内视镜的出现，为手术治疗带来了关键性的转捩点，这主要源自于对感染预防、工作流程效率和临床医师便利性这三者之间紧密相关的需求。一次性内视镜挑战了传统的再处理模式，无需复杂的灭菌流程，从而降低了交叉感染的风险，并缩短了手术间的周转时间。同时，技术的进步提高了影像品质、操作性和与数位平台的整合度，使一次性内视镜成为越来越多临床适应症的可行选择。

技术成熟度、优先考虑感染预防、采购创新和永续性如何重塑部署模式和竞争定位。

一次性内视镜产业正经历一场变革，其意义远不止于简单地取代可重复使用设备。首先，技术的成熟提升了光学性能、人体工学设计和设备可靠性，提高了一次性内视镜平台的临床可靠性，使其能够应用于更广泛的手术操作。其次，供应链的创新和生产规模的扩大正逐步缩小一次性内视镜与可重复使用系统之间的性价比差距，在某些特定应用情境下，采购决策也倾向于选择一次性产品。第三，备受瞩目的感染事件和公众意识的提高，使得人们更加重视感染预防，更加关注设备间的交叉感染风险，从而推动了医疗机构对一次性内视镜产品的需求。

评估新关税措施对一次性内视镜供应链经济、筹资策略和区域製造决策的连锁影响。

2025年实施的新关税政策改变了进口零件、组装和成品的相对贸易经济性，给一次性内视镜供应链带来了巨大压力。关键零件和成品进口关税的提高增加了买家的总成本，并促使製造商重新评估其地理布局、供应商合约和库存策略。为此，各组织正在加快降低成本风险的步伐，包括供应商多元化、启动近岸外包和区域製造伙伴关係以及重新谈判长期合约。

详细的细分洞察揭示了产品类别、设备类型、临床应用、最终用户特征和分销管道如何塑造差异化的商业化策略。

在一次性内视镜领域，清晰的产品细分和临床应用决定了创新重点和市场推广路径。按产品划分，支气管镜、大肠镜和软式内视镜视镜和硬式内视镜之间的差异影响着设计权衡、成本结构以及对不同治疗环境的适用性，因为临床医生会评估其操作性、可视性和触觉回馈。按应用划分，关节镜、支气管镜、耳鼻喉科内视镜、胃肠内视镜和泌尿系统内视镜等多种应用，需要针对每个专科的复杂手术流程和诊断成像需求制定个性化的设备规格和临床检验。

影响美洲、欧洲、中东和非洲以及亚太地区采购和商业化方法的关键区域趋势，以及每个地区不同的采用路径。

区域趋势影响关键市场的采用速度和竞争策略，而影响策略的因素和限制因素因地区而异。在美洲，医疗保健系统正努力在满足感染控制需求的同时，优化处理能力并应对成本削减的压力，这促使医疗机构在风险较高或周转率较高的手术领域选择性地采用一次性产品。市场活动的特点是策略采购合约、试验计画以及对生命週期成本分析日益增长的关注。在欧洲、中东和非洲，由于法律规范、报销结构和医疗服务模式的区域差异，市场状况呈现多样化的特征。一些市场正在迅速采用一次性产品来解决污染问题，而另一些市场则采取更为谨慎的态度，等待成本效益的证据以及与环境政策的契合度。

製造商、新参与企业和分销合作伙伴之间的竞争动态和策略行动，优先考虑临床证据、规模和综合服务交付。

一次性内视镜市场的竞争格局日益取决于企业整合临床可靠性、生产规模和服务导向商业计划的能力。领先的製造商正加大对临床试验、可用性测试和上市后监测的投入，以支持其安全性和有效性声明，同时扩大产能并增强供应链韧性，以满足不断变化的需求。医疗设备开发商与临床机构之间的合作日益普遍，以此加速真实世界证据的累积和临床医生的认可；而与契约製造的合作则有助于实现更灵活的产能管理和成本优化。

为製造商和医疗保健系统提供实用策略指南，以协调临床证据、供应弹性、定製商业模式和永续性倡议，从而促进其应用。

产业领导者应优先考虑多管齐下的策略，将产品创新与采购实际情况、临床检验和永续性相结合。首先，投资于有针对性的临床证据项目，以证明产品在特定应用场景下具有等效性或优越性，重点关注患者安全结果和营运指标，例如周转时间和再处理负担。其次，优化製造和采购策略，透过零件供应商多元化、探索区域製造伙伴关係关係以及建立灵活的契约製造筹资策略，降低关税和供应链中断带来的风险。第三，发展差异化的商业模式，以满足门诊手术中心、诊断中心和医院/诊所的需求，并提供客製化的价格、服务套餐和培训，以加速产品推广应用。

为了确保实用见解和明确的局限性，我们采用了严格的混合方法研究方法，结合了关键相关人员的访谈、第二手资料的整合和迭代检验。

本分析的调查方法结合了质性一手研究、结构化二手研究和迭代检验，确保了研究的稳健性和相关性。一手数据来自对临床医生、采购经理、监管专家和供应链高阶主管的深入访谈，从而深入观点临床绩效标准、采购限制和营运重点。二手研究则利用监管出版刊物、临床文献、产业白皮书和公开的政策文件，取得医疗设备标准、感染预防指南和环境政策趋势的背景资讯。

最终的综合分析平衡了感染预防、营运效率、供应链权衡和永续性责任等方面的益处，从而指导策略决策。

一次性内视镜代表着手术器械策略的关键转折点，它在感染控制和工作流程效率方面带来了切实的好处，同时也对成本结构、永续性和供应链设计提出了新的考量。随着一次性使用平台临床表现的不断提升，其普及程度将取决于製造商能否充分证明其临床价值、解决采购和定价方面的复杂性，以及展现可靠的环境管理能力。因此，医疗机构和门诊服务提供者必须认真权衡感染控制方面的即时效益与长期总成本和环境责任之间的利弊，而循证试验计画和分阶段实施则是一种审慎的做法。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：一次性内视镜市场：依产品分类

  • 支气管镜检查
  • 大肠镜检查
  • 十二指肠内视镜检查

第九章：一次性内视镜市场：按类型划分

  • 软式内视镜
  • 硬式内视镜

第十章：一次性内视镜市场：依应用领域划分

  • 关节镜
  • 支气管镜检查
  • 耳鼻喉内视镜检查
  • 胃肠内视镜检查
  • 泌尿系统视镜检查

第十一章：一次性内视镜市场：依最终用户划分

  • 门诊手术中心
  • 诊断中心
  • 医院和诊所

第十二章：一次性内视镜市场：依通路划分

  • 直销
  • 在线的

第十三章：一次性内视镜市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：一次性内视镜市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：一次性内视镜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国一次性内视镜市场

第十七章：中国一次性内视镜市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3NT Medical, Inc.
  • Altek Corporation
  • Ambu A/S
  • B. Braun Melsungen AG
  • BioVision Technologies, LLC by ATL Technology, LLC
  • Boston Scientific Corporation
  • Daichuan Medical（Shenzhen）Co., Ltd
  • Dyne Medical Group
  • EnlightenVue, Inc.
  • Flexicare Medical Limited
  • Fujifilm Holdings Corporation
  • Hill-Rom Holdings, Inc.
  • Integrated Endoscopy
  • Intersurgical Ltd.
  • IQ Endoscopes Limited
  • J-Sol Medical Co., Ltd.
  • Karl Storz SE & Co. KG
  • NeoScope, Inc.
  • Olympus Corporation
  • OTU Medical Inc.
  • Parburch Medical Developments Ltd
  • PENTAX Medical
  • Scivita Medical Technology Co., Ltd.
  • STERIS Corporation
  • Teleflex Incorporated
  • The Cooper Companies, Inc.
  • The Surgical Company
  • Verathon Inc. by Roper Technologies, Inc.
  • Zhejiang Geyi Medical Instrument Co., Ltd.
  • Zsquare Ltd.
Product Code: MRR-A339DAEFA6BA

The Disposable Endoscopes Market was valued at USD 1.98 billion in 2025 and is projected to grow to USD 2.25 billion in 2026, with a CAGR of 14.95%, reaching USD 5.27 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.98 billion
Estimated Year [2026] USD 2.25 billion
Forecast Year [2032] USD 5.27 billion
CAGR (%) 14.95%

A concise introduction to the disruptive rise of single-use endoscopes and how infection control, workflow efficiency, and clinical expectations converge to redefine procedural care

The emergence of disposable endoscopes has introduced a pivotal inflection point in procedural care, driven by converging imperatives around infection prevention, workflow efficiency, and clinician convenience. Single-use endoscopes challenge traditional reprocessing paradigms by eliminating the need for complex sterilization cycles, thereby reducing cross-contamination risk and shortening turnaround times between procedures. In parallel, technological advances have improved image quality, maneuverability, and integration with digital platforms, making disposables a viable alternative for a growing set of clinical indications.

Adoption is being shaped by an evolving interplay among hospital administrators, procurement teams, and clinicians who must weigh per-procedure costs against operational savings and patient safety gains. At the same time, payers and health systems are scrutinizing total cost of care implications, while regulatory agencies refine expectations for product performance and post-market surveillance. Consequently, manufacturers, distributors, and health systems are all recalibrating strategies to address procurement complexity, clinician acceptance, and lifecycle sustainability, establishing a new competitive dynamic in endoscopy.

How technological maturation, infection prevention priorities, procurement innovation, and sustainability commitments are reshaping adoption patterns and competitive positioning

The disposable endoscope sector is undergoing transformative shifts that extend beyond mere substitution of reusable devices. First, technological maturation has elevated the clinical credibility of disposable platforms through enhancements in optics, ergonomics, and device reliability, enabling use across a wider range of procedures. Second, supply chain innovation and manufacturing scale are progressively narrowing the price-performance differential relative to reusable systems, altering procurement calculus in favor of disposables for selected use cases. Third, heightened emphasis on infection prevention, catalyzed by high-profile contamination incidents and heightened public awareness, has sharpened attention on device-to-device cross-contamination risks and driven institutional demand for single-use alternatives.

Moreover, environmental sustainability considerations are driving parallel investments in product lifecycle management, recyclable materials, and device take-back programs, prompting a rethinking of single-use paradigms to incorporate circularity principles. Concurrently, payer scrutiny and contracting dynamics are encouraging bundled procurement approaches and outcome-based purchasing, which in turn incentivize manufacturers to demonstrate clear value propositions through clinical evidence, operational analytics, and cost-of-care modeling. As these shifts coalesce, the market is evolving from early-adopter experimentation to more standardized adoption pathways that prioritize demonstrable clinical and operational benefits.

Assessing the cascading effects of new tariff measures on supply chain economics, procurement strategies, and regional manufacturing decisions for disposable endoscopes

The introduction of new tariff policies in 2025 has exerted measurable pressure on the disposable endoscope supply chain by altering the relative economics of imported components, assembly, and finished-device shipments. Increased import duties on key components or finished products raise landed costs for buyers and create incentives for manufacturers to reassess geographic footprint, supplier contracts, and inventory strategies. In response, organizations are accelerating initiatives to diversify supplier bases, initiate nearshoring or regional manufacturing partnerships, and renegotiate long-term agreements to mitigate cost exposure.

These adjustments are prompting stakeholders to carry out more rigorous procurement scenario planning, including sensitivity analyses that consider tariff pass-through to end users, contract repricing triggers, and potential shifts in distribution models. At the same time, tariffs are motivating investments in localized manufacturing capabilities and contract manufacturing arrangements that prioritize supply continuity and tariff avoidance. While these moves can stabilize supply and control costs over the medium term, they require capital investment, supplier due diligence, and careful management of regulatory approvals across jurisdictions. Overall, tariffs are acting as a catalyst for supply chain resilience, regionalization strategies, and a reevaluation of total landed cost frameworks.

Granular segmentation insights revealing how product classes, device types, clinical applications, end-user characteristics, and distribution channels inform differentiated commercialization strategies

Distinct product segments and clinical applications are shaping both innovation priorities and adoption pathways in the disposable endoscope arena. Based on Product, the market differentiation across bronchoscopes, colonoscopes, and duodenoscopes reflects divergent technical requirements, sterility risk profiles, and clinical workflows, with each product class presenting unique performance thresholds and value metrics. Based on Type, the contrast between flexible endoscopes and rigid endoscopes influences design trade-offs, cost structures, and suitability for different procedural settings, as clinicians evaluate maneuverability, visualization, and tactile feedback. Based on Application, the application mix spanning arthroscopy, bronchoscopy, ENT endoscopy, gastrointestinal endoscopy, and urologic endoscopy demands tailored device specifications and clinical validation to meet the procedural complexity and imaging expectations of each specialty.

Furthermore, based on End-User, the needs of ambulatory surgical centers, diagnostic centers, and hospitals & clinics diverge significantly in terms of procedure volume, procurement cycles, and infection control protocols, which in turn affects preference for disposables versus reusables. Finally, based on Distribution Channel, direct sell models and online channels introduce different cost-to-serve dynamics, after-sales support expectations, and procurement behaviors. Taken together, segmentation-driven insights underscore the necessity for manufacturers to develop differentiated go-to-market strategies, clinical evidence plans, and pricing models that align with the clinical, operational, and economic priorities unique to each segment.

Key regional dynamics and differentiated adoption pathways across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement and commercialization approaches

Regional dynamics are shaping adoption velocities and competitive tactics across key markets, with different drivers and constraints influencing strategy. In the Americas, health systems are balancing infection control imperatives and throughput optimization against cost containment pressures, which is driving selective adoption in high-risk or high-turnover procedural areas; market activity is characterized by strategic procurement agreements, pilot programs, and increasing interest in lifecycle cost analyses. In the Europe, Middle East & Africa region, divergent regulatory frameworks, reimbursement structures, and healthcare delivery models create a heterogeneous landscape in which some markets adopt disposables rapidly to address contamination concerns, while others proceed more cautiously pending cost-effectiveness evidence and environmental policy alignment.

In the Asia-Pacific region, high procedural volumes, growing healthcare infrastructure investments, and localized manufacturing capabilities are accelerating uptake and fostering competitive entry by regional players. At the same time, clinicians and administrators across all regions are converging on common themes: the need for robust clinical evidence, transparent total cost comparisons, and practical sustainability measures that address end-of-life device management. Consequently, regional strategies that combine clinical partnerships, regulatory navigation, and tailored commercial models are essential to realize adoption while managing payer and public expectations.

Competitive dynamics and strategic behaviors among manufacturers, new entrants, and distribution partners that prioritize clinical evidence, scale, and integrated service offerings

Competitive dynamics in the disposable endoscope market are increasingly defined by the ability to integrate clinical credibility, manufacturing scale, and service-oriented commercial programs. Leading manufacturers are investing in clinical studies, usability testing, and post-market surveillance to substantiate safety and efficacy claims while also expanding production capacity and supply chain resilience to meet demand volatility. Partnerships between device developers and clinical institutions are becoming more common as a route to accelerate real-world evidence generation and clinician acceptance, and collaborations with contract manufacturers are enabling more flexible capacity management and cost optimization.

At the same time, new entrants and niche specialists are targeting specific procedural segments where disposable solutions can quickly demonstrate operational advantages, such as high-infection-risk environments or low-volume facilities that cannot justify reusable reprocessing infrastructure. Distribution strategies are evolving as well, with hybrid approaches that combine direct sales to large health systems and digital channels for smaller clinics, accompanied by service offerings like device take-back programs, training modules, and analytics dashboards to track usage and outcomes. Overall, companies that can deliver integrated solutions that address clinical performance, procurement simplicity, and environmental stewardship will be best positioned to capture sustained adoption.

Actionable strategic playbook for manufacturers and health systems to align clinical evidence, supply resilience, tailored commercial models, and sustainability commitments to drive adoption

Industry leaders should prioritize a multi-dimensional strategy that aligns product innovation with procurement realities, clinical validation, and sustainability commitments. First, invest in targeted clinical evidence programs that demonstrate procedural equivalence or superiority in defined use cases, focusing on patient safety outcomes and operational metrics such as turnover time and reprocessing burden. Second, optimize manufacturing and sourcing strategies to reduce exposure to tariff and supply chain disruptions by diversifying component suppliers, exploring regional manufacturing partnerships, and establishing flexible contract manufacturing arrangements. Third, develop differentiated commercial models that reflect the needs of ambulatory surgical centers, diagnostic centers, and hospitals & clinics, offering tailored pricing, service bundles, and training to accelerate uptake.

In addition, embed environmental mitigation measures into product design and lifecycle planning, including recyclable materials, take-back schemes, and transparent end-of-life reporting to address sustainability concerns and satisfy stakeholder scrutiny. Finally, invest in digital tools and analytics that provide procurement and clinical leaders with actionable insights on device utilization, cost per procedure drivers, and compliance, thereby strengthening the case for adoption while supporting continuous improvement in clinical workflows.

Rigorous mixed-methods research approach combining primary stakeholder interviews, secondary evidence synthesis, and iterative triangulation to ensure actionable insights and transparent limitations

The research methodology underpinning this analysis combines qualitative primary research with structured secondary investigation and iterative triangulation to ensure robustness and relevance. Primary inputs were synthesized from in-depth interviews with clinicians, procurement leaders, regulatory specialists, and supply chain executives, providing practical perspectives on clinical performance criteria, purchasing constraints, and operational priorities. Secondary research drew on regulatory publications, clinical literature, industry white papers, and publicly available policy communications to establish context on device standards, infection prevention guidance, and environmental policy trends.

Data synthesis employed cross-validation techniques to reconcile divergent stakeholder viewpoints and to surface consensus recommendations. Limitations of the methodology include the variable availability of published clinical outcomes across specific product classes and the evolving nature of trade and regulatory policies, which require ongoing monitoring. To mitigate these limitations, the study incorporates scenario analysis and sensitivity testing of strategic options, enabling decision-makers to assess potential pathways under differing regulatory, reimbursement, and supply chain conditions.

Concluding synthesis that balances infection prevention advantages, operational efficiencies, supply chain trade-offs, and sustainability responsibilities to guide strategic decision-making

Disposable endoscopes represent a consequential shift in procedural device strategy, offering tangible benefits in infection prevention and workflow efficiency while introducing new considerations around cost structure, sustainability, and supply chain design. As clinical capabilities of single-use platforms continue to improve, adoption will be shaped by the degree to which manufacturers can substantiate clinical value, resolve procurement and pricing complexities, and demonstrate credible environmental stewardship. Health systems and ambulatory providers must therefore navigate trade-offs between immediate infection control benefits and longer-term total cost and environmental obligations, making evidence-based pilot programs and phased rollouts prudent approaches.

Ultimately, the trajectory of disposable endoscope adoption will hinge on collaborative efforts among device manufacturers, clinical champions, procurement organizations, and policymakers to align incentives and to develop pragmatic frameworks for evaluation, procurement, and lifecycle management. Those stakeholders who proactively address clinician training, supply chain resilience, and sustainability are most likely to translate early commitments into measurable clinical and operational gains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Disposable Endoscopes Market, by Product

  • 8.1. Bronchoscopes
  • 8.2. Colonoscopes
  • 8.3. Duodenoscopes

9. Disposable Endoscopes Market, by Type

  • 9.1. Flexible Endoscopes
  • 9.2. Rigid Endoscopes

10. Disposable Endoscopes Market, by Application

  • 10.1. Arthroscopy
  • 10.2. Bronchoscopy
  • 10.3. ENT Endoscopy
  • 10.4. Gastrointestinal Endoscopy
  • 10.5. Urologic Endoscopy

11. Disposable Endoscopes Market, by End-User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals & Clinics

12. Disposable Endoscopes Market, by Distribution Channel

  • 12.1. Direct Sell
  • 12.2. Online

13. Disposable Endoscopes Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Disposable Endoscopes Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Disposable Endoscopes Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Disposable Endoscopes Market

17. China Disposable Endoscopes Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3NT Medical, Inc.
  • 18.6. Altek Corporation
  • 18.7. Ambu A/S
  • 18.8. B. Braun Melsungen AG
  • 18.9. BioVision Technologies, LLC by ATL Technology, LLC
  • 18.10. Boston Scientific Corporation
  • 18.11. Daichuan Medical (Shenzhen) Co., Ltd
  • 18.12. Dyne Medical Group
  • 18.13. EnlightenVue, Inc.
  • 18.14. Flexicare Medical Limited
  • 18.15. Fujifilm Holdings Corporation
  • 18.16. Hill-Rom Holdings, Inc.
  • 18.17. Integrated Endoscopy
  • 18.18. Intersurgical Ltd.
  • 18.19. IQ Endoscopes Limited
  • 18.20. J-Sol Medical Co., Ltd.
  • 18.21. Karl Storz SE & Co. KG
  • 18.22. NeoScope, Inc.
  • 18.23. Olympus Corporation
  • 18.24. OTU Medical Inc.
  • 18.25. Parburch Medical Developments Ltd
  • 18.26. PENTAX Medical
  • 18.27. Scivita Medical Technology Co., Ltd.
  • 18.28. STERIS Corporation
  • 18.29. Teleflex Incorporated
  • 18.30. The Cooper Companies, Inc.
  • 18.31. The Surgical Company
  • 18.32. Verathon Inc. by Roper Technologies, Inc.
  • 18.33. Zhejiang Geyi Medical Instrument Co., Ltd.
  • 18.34. Zsquare Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DISPOSABLE ENDOSCOPES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DISPOSABLE ENDOSCOPES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DUODENOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DUODENOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY BRONCHOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ENT ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ENT ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ENT ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY UROLOGIC ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY UROLOGIC ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY UROLOGIC ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIRECT SELL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIRECT SELL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY DIRECT SELL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 113. GCC DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 131. G7 DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 134. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 137. NATO DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL DISPOSABLE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA DISPOSABLE ENDOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)